Survival time in mice bearing TLX5 lymphoma subjected to rotational stress and chemotherapy with CCNU

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4355-4357

  Perissin, Laura ^a   Rapozzi, Valentina ^a   Zorzet, Sonia ^b   Giraldi, Tullio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antitumor chemotherapy; Mice; Stress; TLX5 lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; LYMPHOMA; MENTAL STRESS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRESS; SURVIVAL TIME;

EID: 0031418808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Justice A. Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychol Bull 98: 108-138, 1985.
2. Withers HR, Milas L: Influence of preirradiation of lung on development of artificial pulmonary mertastases of fibrosarcoma in mice. Cancer Res 33: 1931-1936, 1973.
3. Furuse T, Kasuga T: Effects of irradiation with fast neutrons or X-rays on the incidence of metastasis of transplanted B16 melanoma in mice. Gann 73: 35-41, 1982.
4. Peters LJ. A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer 32: 355-365, 1975.
5. deRuiter J, Cramer SJ, Smink T, van Putten LM: The facilitation of tumor growth in the lung by cyclophosphamide in artificial and spontaneous metastases models. Eur J Cancer Clin Oncol 15: 1139-1149, 1979.
6. Orr FW, Adamson IJR, Young L: Promotion of pulmonary metastasis in mice bleomycin-induced endotelial injury. Cancer Res 46: 891-897, 1986.
7. Ormerod EJ, Everett CA, Hart IR: Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine. Cancer Res 46: 884-890, 1986.
8. Lundy J, Lowett EJ, Hamilton S, Conran P: Halothane, surgery, imunosuppression and artificial pulmonary metastases. Cancer 41: 827-830, 1978.
9. Agostino D, Agostino N: Role of operative trauma: explosive metastases of similar size following amputation of the primary leg tumor. Tumori 65: 527-538, 1979.
10. Pollock RE, Babacock GF, Ronsdahl MM, Mishioka K: Surgical stress-mediated suppression of murine natural killer cell cytotoxicity. Cancer Res 44: 3888-3891, 1984.
11. Steplewski Z, Robinson Goldman P, Vogel WH: Effect of housing stress on the formation and development of tumors in rats. Cancer Lett 34: 257-261, 1987.
12. Riley V, Fitzmaurice MA, Spackman DH: Animals models in biobehavioral research: effects of anxiety stress on immunocompetence and neoplasia. In: Perspectives on behavioral medicine (Weiss SM, Herd JA and Fox BH, eds.). New York, Academic Press, pp 371-400, 1981.
13. LaBarba RC: Experiential and environmental factors in cancer. Psychosom Med 32: 258-276, 1970.
14. Kaliss N, Fuller JL: Incidence of lymphatic leukemia and methylcolanthrene-induced cancer in laboratory mice subjected to stress. JNCI 41: 967-981, 1968.
15. Sklar LS, Anisman H: Stress and coping factors influence tumor growth. Science 205: 513-515, 1979.
16. Labarba RC: Experiential and environmental factors in cancer. A review of research with animals. Psychosom Med 32: 259-276, 1979.
17. Gershbein LL, Benuck I, Shurrager PS: Influence of stress on lesion growth and on survival animals bearing parenteral and intracerebral leukemia L1210 and Walker tumors. Oncology 30: 429-435, 1974.
18. Gotoh T, Lee G, Yoshikura H: Effects of physical restraint on leukemogenesis by Friend virus. GANN 77: 985-991, 1986.
19. Giraldi T, Perissin L, Zorzet S, Piccini P, Rapozzi V: Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma. Eur J Cancer Clin Oncol 25: 1583-1588, 1989.
20. Steinberg D, Colla P: Survival: a supplementary module for Systat. Evanston: IL: SYSTAT Inc., 1988.
21. Perissin L, Zorzet S, Piccini P, Rapozzi V, Giraldi, T: Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma. Clin Exp Metastasis 9: 541-549, 1991.
22. Kerr LR, Grimm MS, Silva WA, Weinberg J, Emerman JT: Effects of social housing condition on the response of Shionogi mouse mammary carcinoma (SC115) to chemotherapy. Cancer Res 57: 1124-1128, 1997
23. Vogel WH, Bower DB: Stress, immunity and cancer. In: Stress and immunity (Plotnikoff N, Murgo A, Faith R and Wybran J, eds.) London, CRC Press, pp 493-507, 1991.
24. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S: Increase in the effectiveness of melphalan therapy with progression of MOP-315 plasmacytoma tumor growth. Cancer Immunol Immunother 15: 101-107, 1983.
25. Berko R, Seissman K, Colvin M, Bocian RC, Ben-Efraim S, Dray S: Tumoricidal and immunomodulatory activities of drugs and implications for therapy of mice bearing a late stage MOPC-315 plasmacytoma. Int J Immunopharmacol 10: 825-834, 1988 .
26. Mokyr MB, Dray S: Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide. Cancer Res 43: 3112-3119, 1983.
27. Hengst JC, Mokyr MB, Dray S: Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res 41: 2163-2167, 1981.
28. Mokyr MB, Brundett RB, Colvin M, Dray S: Ability of cyclophosphamide in the absence of cross-linking activity to exert the immunomodulatory effect required for the cure of mice bearing a large MOPC-315 tumor. Cancer Res 46: 3313-3320, 1986.
29. Mokyr MB, Baker E, Weiskirch LM, Takesue BY, Pyle JM: Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor. Cancer Res 49: 4597-4606, 1989.
30. Morikawa K, Hosokawa M, Hamada J, Sugawara M, Kobayashi H: Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res 45: 1502-1506, 1985.
31. Morris T, Pettingale K, Haybittle J: Psychological responses to cancer diagnosis and disease outcome in patients with breast cancer and lymphoma. Psychooncology 1: 105-114, 1992.